Idiopathic pulmonary fibrosis (IPF) is the most common and lethal form of idiopathic
interstitial pneumonia. The disease, which occurs primarily in middle-aged and older adults …

Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial
pneumonias. It is characterized by a chronic, progressive, fibrotic interstitial lung disease of …

Lung transplantation is the only intervention that prolongs survival in idiopathic pulmonary
fibrosis (IPF). Telomerase mutations are the most common identifiable genetic cause of IPF …

Rationale: Idiopathic pulmonary fibrosis (IPF) causes progressive lung scarring and high
mortality. Reliable and accurate prognostic biomarkers are urgently needed. Objectives: To …

Background Single-cell transcriptomic studies have greatly improved organ-specific insights
into macrophage polarization states are essential for the initiation and resolution of …

Background Pulmonary fibrosis (PF) is the most common disease indication for lung
transplantation. Our recent work implicated an excess of rare genetic variants in the …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive diffuse parenchymal lung
disease of unknown origin, with a mortality rate exceeding that of many cancers. The …

La fibrosis pulmonar idiopática se define como una neumonía intersticial fibrosante crónica,
limitada al pulmón, de causa desconocida, con mal pronóstico y escasas opciones …

Idiopathic Pulmonary fibrosis (IPF) is diagnosed as a life-threatening, progressive and
incurable lung disease characterized by accumulation of extracellular matrix and …

Abstract Sphingosine-1-phosphate (S1P), a simple, bioactive sphingolipid metabolite, plays
a key role, both intracellularly and extracellularly, in various cellular processes such as …